The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks sink on fears of Ukraine conflict

Mon, 24th Jan 2022 12:20

(Alliance News) - Stock prices in London were sharply lower at midday on Monday amid market unease over the standoff on the border of Ukraine as the US ordered families of Ukraine embassy staff to leave.

However, Ukraine said it was "premature" of the US to evacuate the families of its diplomatic staff in Kyiv due to fears of a looming Russian invasion. "We consider such a step by the American side premature and a display of excessive caution," Ukrainian foreign ministry spokesman Oleg Nikolenko said in a statement.

The EU is not following the US in withdrawing its diplomats' families from Ukraine, top European diplomat Josep Borrell said, adding that there was no need to "dramatise" the situation while talks with Russia continue.

"We are not going to do the same thing because we don't know any specific reasons," Borrell said as he arrived for a meeting of EU foreign ministers which will include videolink participation by US Secretary of State Antony Blinken.

The West says Russia has been massing tens of thousands of troops on its border with Ukraine, along with an arsenal of tanks, fighting vehicles, artillery and missiles.

The Kremlin insists its forces are not there to invade and on Monday accused the US and NATO of ramping up tensions, after the Western military bloc said it was bolstering Europe's eastern defences.

Kremlin spokesman Dmitry Peskov said Washington and NATO were escalating tensions through "information hysteria" and "concrete actions," adding that the risk of an offensive by Ukrainian troops against pro-Russia separatists was "very high".

The FTSE 100 index was down 87.81 points, or 1.2%, at 7,406.32. The mid-cap FTSE 250 index was down 480.24 points, or 2.2%, at 21,782.40. The AIM All-Share index was down 35.20 points, or 3.1%, at 1,096.88.

The Cboe UK 100 index was down 1.0% at 736.17. The Cboe 250 was down 2.3% at 19,515.24 and the Cboe Small Companies down 2.2% at 15,294.49.

In mainland Europe, the CAC 40 stock index in Paris was down 1.7%, while the DAX 40 in Frankfurt was down 1.6%.

"Anyone hoping for a measure of calm on the markets after a testing period is likely to be disappointed as we start what could be another turbulent week," said AJ Bell investment director Russ Mould.

"The shifting market landscape is further complicated by the increasingly noisy sabre rattling by Russia on the Ukrainian border. Escalation to a full armed conflict is likely to prompt market volatility and potentially a further surge in energy prices - only adding to the current inflationary pressures," Mould added.

In the FTSE 100, Unilever was the best performer, up 5.8%. Trian Partners has built a stake in the Dove soap maker, turning up the pressure on the FTSE 100 company after its failed pursuit of GlaxoSmithKline's consumer health business, the Financial Times reported at the weekend.

Citing people familiar with the matter, the newspaper said Nelson Peltz's activist hedge fund had taken an unspecified position in the Unilever shares, adding to the challenges facing Chief Executive Officer Alan Jope.

The FT said people with knowledge of the stakebuilding did not provide details on its size or when precisely it began. Last week, Unilever said it would not increase its offer for Glaxo's Consumer Healthcare unit above GBP50 billion following three failed bids. Glaxo was up 0.7%.

Hargreaves Lansdown was up 3.0% after Bank of America upgraded the fund supermarket to Buy from Neutral.

At the other end of the large-caps, Barratt Developments was down 6.6%. Jefferies downgraded the housebuilder to Hold from Buy.

Pearson was down 5.5% after UBS cut the education publisher to Sell from Neutral.

In the FTSE 250, Ferrexpo was down 7.5% after Peel Hunt downgraded the iron pellets producer to Hold from Buy. The Ukraine-focused stock also was hurt by the country's tensions with Russia.

Elsewhere in London, De La Rue was down 23%. The banknote printer warned that annual profit will miss market expectations due to significant pressure from the extended Covid-19 pandemic.

For the financial year ending March 26, De La Rue expects adjusted operating profit to come between GBP36 million and GBP40 million, flat on GBP38.1 million in the prior year but below market expectations of GBP45 million to GBP47 million.

In addition, the company is dealing with higher commodity and energy costs and with supply chain shortages in chips and other raw materials.

The pound was quoted at USD1.3497 at midday on Monday, lower from USD1.3550 at the London equities close Friday, following disappointing PMI data from the UK.

UK private sector growth slowed in January as the Omicron variant of Covid-19 continued to weigh on customer-facing parts of the economy.

The IHS Markit-CIPS UK services purchasing managers' index reading was 53.3 points in January, down slightly from 53.6 in December. The flash print remained above the 50.0 neutral mark but missed the market forecast, cited by FXStreet, of 55.0. January's reading was also the lowest in 11 months.

The UK manufacturing PMI slipped to 56.9 points in January from 57.9 in December and missed the market estimate for the same score as registered in December.

The UK composite PMI, the combination of the two sectors, edged down to an 11-month low of 53.4 in January from 53.6 in December.

The euro was priced at USD1.1312, down from USD1.1343. Against the Japanese yen, the dollar was trading at JPY113.73, fractionally lower on JPY113.75.

On the continent, private sector growth in the eurozone slowed for a second successive month in January, preliminary survey results from IHS Markit showed.

The eurozone flash composite PMI slid to 52.4 points in January from 53.3 in December - hitting an 11-month low. The flash services PMI activity index declined to 51.2 points from 53.1, while the manufacturing PMI improved to 59.0 from 58.0.

Brent oil was quoted at USD87.87 a barrel on Monday at midday, up from USD87.74 late Friday. Gold stood at USD1,837.30 an ounce, higher against USD1,833.20.

New York was called sharply lower as the negative start for US equities in 2022 looks set to continue with the US Federal Reserve's first policy meeting of the year getting underway on Tuesday.

The Dow Jones Industrial Average was called down 1.5%, the S&P 500 down 2.1%, and the Nasdaq Composite down 3.2%, based on futures trading.

"Last week's important bearish corrections on most benchmarks can be seen as a sign the hawkish switch from the Fed was already being priced in. That said, Fed Chair Jerome Powell's words will be cautiously analysed in order to get more clues about the schedule and pace of incoming rates hikes and balance sheet reductions, which is likely to spark increased volatility towards riskier assets," said Pierre Veyret, technical analyst at ActivTrades.

Earnings season in New York continues this week with high-profile names Microsoft, Tesla and Apple reporting on Tuesday, Wednesday and Thursday, respectively.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.